These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 33216495)

  • 21. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer.
    Kim HJ; Choi GS; Seo AN; Park JS; Park SY; Cho SH; Yoon G
    Dis Colon Rectum; 2021 Aug; 64(8):955-963. PubMed ID: 33938533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Size Criteria Is Not Sufficient in Selecting Patients for Local Excision Versus Radical Excision for Rectal Neuroendocrine Tumors >2 cm: A National Cancer Database Analysis.
    Izquierdo KM; Humphries MD; Farkas LM
    Dis Colon Rectum; 2021 Apr; 64(4):399-408. PubMed ID: 33651006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Significance of Systemic Inflammation Indices by K-ras Status in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Akiyama T; Kato R; Sawayama H; Ogawa K; Yoshida N; Baba H
    Dis Colon Rectum; 2023 Aug; 66(8):e809-e817. PubMed ID: 35195557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
    Kyong Shin J; Ah Park Y; Wook Huh J; Hyeon Yun S; Cheol Kim H; Yong Lee W; Hyung Kim S; Yun Ha S; Cho YB
    Dis Colon Rectum; 2023 Aug; 66(8):e801-e808. PubMed ID: 35394982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined Comprehensive Risk Score of the Estimation of Physiologic Ability and Surgical Stress and C-Reactive Protein-to-Albumin Ratio Is a Strong Prognostic Indicator of Long-term Outcomes in Colorectal Cancer.
    Kato Y; Shigeta K; Tajima Y; Nakadai J; Seo Y; Kikuchi H; Seishima R; Okabayashi K; Kitagawa Y
    Dis Colon Rectum; 2024 Oct; 67(10):1271-1280. PubMed ID: 38902835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Clinicopathological Characteristics of Appendiceal Tumors in Japan: A Multicenter Collaborative Retrospective Clinical Study- A Japanese Nationwide Survey.
    Matsui S; Murata K; Fukunaga Y; Takeda T; Fujii M; Yamaguchi T; Kagawa Y; Mizushima T; Ohno Y; Yao T; Doki Y; Sugihara K
    Dis Colon Rectum; 2020 Oct; 63(10):1403-1410. PubMed ID: 32969883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
    Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
    Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Cost Analysis Between Endoscopic Resection and Surgery for Submucosal Colorectal Cancer.
    Noh SM; Hwang SW; Park SH; Yang DH; Ye BD; Park IJ; Lim SB; Byeon JS
    Dis Colon Rectum; 2023 May; 66(5):723-732. PubMed ID: 35714338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High World Heath Organization Performance Status Is Associated With Short- and Long-term Outcomes After Colorectal Cancer Surgery: A Nationwide Population-Based Study.
    Bojesen RD; Degett TH; Dalton SO; Gögenur I
    Dis Colon Rectum; 2021 Jul; 64(7):851-860. PubMed ID: 34086001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
    Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonmicroradical Resection Margin as a Predictor of Recurrence in Patients With Stage III Colon Cancer Undergoing Complete Mesocolic Excision: A Prospective Cohort Study.
    Gundestrup AK; Olsen ASF; Ingeholm P; Bols B; Kleif J; Bertelsen CA
    Dis Colon Rectum; 2022 May; 65(5):683-691. PubMed ID: 34933419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
    Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
    Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Impact of Mucinous Adenocarcinoma in Stage II and III Colon Cancer.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park Y; Shin JK
    Dis Colon Rectum; 2023 Nov; 66(11):1473-1480. PubMed ID: 37260257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer.
    Chang KH; Brown KGM; Chen Lau Y; Solomon MJ
    Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn's Disease?
    Bolckmans R; Kalman T; Singh S; Ratnatunga KC; Myrelid P; Travis S; George BD
    Dis Colon Rectum; 2020 Feb; 63(2):200-206. PubMed ID: 31842162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcopenia, as Assessed by Psoas Cross-Sectional Area, Is Predictive of Adverse Postoperative Outcomes in Patients Undergoing Colorectal Cancer Surgery.
    Richards SJG; Senadeera SC; Frizelle FA
    Dis Colon Rectum; 2020 Jun; 63(6):807-815. PubMed ID: 32149784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
    Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
    Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
    Park SY; Lee SM; Park JS; Kim HJ; Choi GS
    Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Tumor Location on Outcome After Laparoscopic Low Rectal Cancer Surgery: A Propensity Score Matching Analysis.
    Wu Q; Jin Z; Zhang X; Deng X; Peng Y; Wang Z
    Dis Colon Rectum; 2022 May; 65(5):672-682. PubMed ID: 35394940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.